Drug Topics July 15, 2025
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discusses how diabetes advancements like GLP-1s and CGM have impacted the management of insulin.
Despite significant advancements in diabetes medication and technology, challenges within insulin management remain for both patients and the pharmacists or specialists counseling them. While significant progress has been made in continuous glucose monitoring (CGM) technology, as well as life-saving glucagon-like peptide-1 (GLP-1) drugs, researchers and providers alike have yet to fully eradicate hypoglycemia among patients with diabetes.
“I think this puts into perspective the challenges with insulin and how there’s still more to be done,” Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, director of education and training in diabetes at Cleveland Clinic, told Drug Topics. “As much as CGM...
Today's Sponsors
Today's Sponsor